Levocetirizine Suppliers & Bulk Manufacturers
Available Forms: Oral Syrup
Available Strengths: 2.5 mg/5 mL; 5 mg/5 mL
Reference Brands: Xyzal Syrup(US & EU); Levocet Syrup(EU)
Category:
Allergy Medication
Levocetirizine Syrup (2.5 mg/5 mL, 5 mg/5 mL) is a non-sedating antihistamine for allergic rhinitis and urticaria. Suitable for children and adults, it offers 24-hour relief with minimal drowsiness. Trusted brands include Xyzal in the US/EU.
Levocetirizine is available in Oral Syrup
and strengths such as 2.5 mg/5 mL; 5 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levocetirizine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levocetirizine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levocetirizine Syrup (2.5 mg/5 mL and 5 mg/5 mL) is a non-sedating, second-generation antihistamine used to treat allergic rhinitis, sneezing, runny nose, itchy eyes, and urticaria in both children and adults. It provides fast, 24-hour relief with minimal drowsiness. Popular brands include Xyzal (US/EU) and Levocet Syrup in other regulated markets. Manufactured in GMP-certified and FDA-compliant facilities, Levocetirizine Syrup is ideal for bulk procurement, private labeling, and B2B distribution in the EU and US pharmaceutical markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing